Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 32.35% is 18% above its 5-year average of 27.52%, near the high end of its 5-year range (24.72%–32.35%).
As of the fiscal period ended Wednesday, December 31, 2025. 10.45% above its 12-month average of 29.29%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
32.35%
RETURN ON ASSETS (ROA) AVG TTM
29.29%
RETURN ON ASSETS (ROA) AVG 3Y
27.30%
RETURN ON ASSETS (ROA) AVG 5Y
27.52%
RETURN ON ASSETS (ROA) AVG 10Y
23.26%
RETURN ON ASSETS (ROA) AVG 15Y
20.74%
RETURN ON ASSETS (ROA) AVG 20Y
19.44%
CURRENT VS TTM AVG
+10.45%
CURRENT VS 3Y AVG
+18.48%
CURRENT VS 5Y AVG
+17.54%
CURRENT VS 10Y AVG
+39.07%
CURRENT VS 15Y AVG
+55.96%
CURRENT VS 20Y AVG
+66.41%
SECTOR MEDIAN · HEALTHCARE
4.93%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+556.19%
vs the sector median at left
IDEXX Laboratories, Inc.
Market Cap
$42.94B
Return on Assets (ROA)
32.35%
TTM Avg
29.29%
3Y Avg
27.30%
5Y Avg
27.52%
Market Cap
$39.14B
Return on Assets (ROA)
10.82%
TTM Avg
10.56%
3Y Avg
11.14%
5Y Avg
10.55%
Market Cap
$47.58B
Return on Assets (ROA)
8.20%
TTM Avg
19.91%
3Y Avg
18.29%
5Y Avg
17.04%
Market Cap
$36.28B
Return on Assets (ROA)
11.25%
TTM Avg
-0.12%
3Y Avg
-10.91%
5Y Avg
-15.37%
Market Cap
$34.72B
Return on Assets (ROA)
4.67%
TTM Avg
4.82%
3Y Avg
4.76%
5Y Avg
4.01%
Market Cap
$32.77B
Return on Assets (ROA)
2.47%
TTM Avg
3.17%
3Y Avg
1.75%
5Y Avg
1.75%
Market Cap
$53.41B
Return on Assets (ROA)
2.75%
TTM Avg
2.42%
3Y Avg
0.86%
5Y Avg
-0.71%
Market Cap
$31.59B
Return on Assets (ROA)
17.44%
TTM Avg
17.37%
3Y Avg
16.33%
5Y Avg
15.33%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IDEXX Laboratories, Inc. (IDXX) | $42.94B | 32.35% | 29.29% | 27.30% | 27.52% |
| Agilent Technologies, Inc. (A)vs › | $39.14B | 10.82% | 10.56% | 11.14% | 10.55% |
| Humana Inc. (HUM)vs › | $46.74B | 2.04% | 2.52% | 4.20% | 5.49% |
| Edwards Lifesciences Corporation (EW)vs › | $47.58B | 8.20% | 19.91% | 18.29% | 17.04% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $36.28B | 11.25% | -0.12% | -10.91% | -15.37% |
| IQVIA Holdings Inc. (IQV)vs › | $34.72B | 4.67% | 4.82% | 4.76% | 4.01% |
| Medline Inc. (MDLN)vs › | $32.77B | 2.47% | 3.17% | 1.75% | 1.75% |
| Cardinal Health, Inc. (CAH)vs › | $53.41B | 2.75% | 2.42% | 0.86% | -0.71% |
| Zoetis Inc. (ZTS)vs › | $31.59B | 17.44% | 17.37% | 16.33% | 15.33% |
| Centene Corp. (CNC)vs › | $31.31B | -7.94% | -2.29% | 0.04% | 0.75% |
ROA
32.4%
ROE
70.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 31.62% |
| 2024-12-31 | 26.96% |
| 2023-12-31 | 25.92% |
| 2022-12-31 | 24.72% |
| 2021-12-31 | 30.56% |
| 2020-12-31 | 25.35% |
| 2019-12-31 | 23.34% |
| 2018-12-31 | 24.52% |
| 2017-12-31 | 15.36% |
| 2016-12-31 | 14.51% |
| 2015-12-31 | 13.02% |
| 2014-12-31 | 13.14% |
| 2013-12-31 | 15.26% |
| 2012-12-31 | 16.15% |
| 2011-12-31 | 15.69% |
| 2010-12-31 | 15.75% |
| 2009-12-31 | 15.12% |
| 2008-12-31 | 15.18% |
| 2007-12-31 | 13.39% |
| 2006-12-31 | 16.74% |
| 2005-12-31 | 15.95% |
| 2004-12-31 | 15.23% |
| 2003-12-31 | 10.94% |
| 2002-12-31 | 10.89% |
| 2001-12-31 | 10.08% |
| 2000-12-31 | 10.91% |
| 1999-12-31 | 9.05% |
| 1998-12-31 | -3.89% |
| 1997-12-31 | -5.60% |
| 1996-12-31 | 8.72% |
